D. Lloyd‐Jones
Cardiology and Cardiovascular Medicine · 2002–2022
A researcher in the Science corpus: 33 papers; trusts 11 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 843 citations into it; #768 of 906 by trust here, #5 by citations
- Endocrinology, Diabetes and Metabolism — 556 citations into it
- Surgery — 495 citations into it
- Economics and Econometrics — 50 citations into it
- Statistics and Probability — 12 citations into it
Whom D. Lloyd‐Jones trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- E. Ford
- Ralph B. D’Agostino
- P. Ridker
- Peter W. F. Wilson
- Ramachandran S. Vasan
- Michael J. Pencina
- Nancy R. Cook
- Martin G. Larson
- Daniel Levy
- F. B. Hu
Who trusts D. Lloyd‐Jones overall
- Véronique L. Roger
- D. Mozaffarian
- Alan S. Go
- Emelia J. Benjamin
- I. Tabas
- I. Graham
- E. Crimmins
- R. Redberg
- R. Shephard
- C. Bushnell
Papers from D. Lloyd‐Jones's perspective
Ordered by how strongly the researchers D. Lloyd‐Jones trusts endorse each paper. Same corpus, a different order for every researcher.
- Rosuvastatin in older patients with systolic heart failure. (Current Atherosclerosis Reports)
- Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. (Journal of the American Medical Association (JAMA))
- Common SNPs explain a large proportion of heritability for human height (Nature Genetics)
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)
- Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. (New England Journal of Medicine)
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. (Circulation)
- Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. (The Lancet)
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
- A new look at the statistical model identification
Their papers
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) — 5,063 citations
- Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association (2022) — 1,919 citations
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary (2019) — 1,563 citations
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) — 1,734 citations
- Recovery of trait heritability from whole genome sequence data (2019) — 222 citations
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) — 4,134 citations
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary (2019) — 721 citations
- Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity (2018) — 912 citations
- Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (2014) — 2,241 citations
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) — 5,681 citations
- ACCF/AHA TASK FORCE MEMBERS (2013) — 770 citations
- Heart disease and stroke statistics--2012 update: a report from the American Heart Association. (2012) — 5,424 citations
- Tree-structured analysis of treatment effects with large observational data (2012) — 19 citations
- Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. (2012) — 1,530 citations
- Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update (2011) — 1,033 citations
- Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association (2011) — 2,972 citations
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. (2011) — 2,055 citations
- Cardiovascular risk prediction: basic concepts, current status, and future directions. (2010) — 719 citations
- Heart Disease and Stroke Statistics—2011 Update (2010) — 5,212 citations
- Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond (2010) — 4,217 citations